Oral tranexamic acid use for melasma is not associated with thromboembolism: Findings from a multicenter propensity score–matched electronic health record cohort

Authors

Tyler Hernandez, LSU Health Sciences Center - New OrleansFollow
Kayla Penny, LSU Health Sciences Center - New OrleansFollow
Nicholas Culotta, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

9-30-2025

Publication Title

JAAD International

First Page

64

Last Page

66

PubMed ID

41256337

Volume

24

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Hernandez, Tyler; Penny, Kayla; and Culotta, Nicholas, "Oral tranexamic acid use for melasma is not associated with thromboembolism: Findings from a multicenter propensity score–matched electronic health record cohort" (2025). School of Medicine Faculty Publications. 4405.
https://digitalscholar.lsuhsc.edu/som_facpubs/4405
10.1016/j.jdin.2025.09.005